Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteria

Hansen, Mathias H.; Stegmann, Evi; Cryle, Max J.

dc.contributor.author	Stegmann, Evi
dc.date.accessioned	2023-06-05T07:14:21Z
dc.date.available	2023-06-05T07:14:21Z
dc.date.issued	2022
dc.identifier.issn	0958-1669
dc.identifier.uri	http://hdl.handle.net/10900/141820
dc.language.iso	en	de_DE
dc.publisher	Current Biology Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.copbio.2022.102767	de_DE
dc.subject.ddc	570	de_DE
dc.title	Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteria	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_01935
utue.personen.roh	Hansen, Mathias H.
utue.personen.roh	Stegmann, Evi
utue.personen.roh	Cryle, Max J.
dcterms.isPartOf.ZSTitelID	Current Opinion in Biotechnology	de_DE
dcterms.isPartOf.ZS-Issue	Article 102767	de_DE
dcterms.isPartOf.ZS-Volume	77	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE